You're 100% right. I replied to that post saying what a good decision it was to include FTO analysis in the Newcastle pre clinical breast cancer study. I'm sure Associate Professor Nikki Verrills is hard at it at the Hunter Institute. If the additional work with FTO adds a bit to the timeframe I am confident it will be worth it. Onward.
Ann: Quarterly Activity Report & Appendix 4C, page-51
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |